BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.
about
The role of natriuretic peptides for the diagnosis of left ventricular dysfunctionClinical Significance of B-type Natriuretic Peptide in Heart FailureHeart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiologyCardiac assessment of patients with late stage Duchenne muscular dystrophy.Quantifying longitudinal right ventricular dysfunction in patients with old myocardial infarction by using speckle-tracking strain echocardiography.Dual-energy CT pulmonary angiography in patients with suspected pulmonary embolism: value for the detection and quantification of pulmonary venous congestion.Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failureThe biological variation of N-terminal pro-brain natriuretic peptide in postmenopausal women with type 2 diabetes: a case control study.Experimental models of duchenne muscular dystrophy: relationship with cardiovascular disease.The role of B-type and other natriuretic peptides in health and disease.Validity of Amino Terminal pro-Brain Natiuretic Peptide in a Medically Complex Elderly Population.In-hospital brain natriuretic peptide and N-terminal prohormone brain natriuretic peptide variations are predictors of short-term and long-term outcome in acute decompensated heart failure.Understanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansionClinical usefulness of B-type natriuretic peptide measurement: present and future perspectives.Early elevations in B-type natriuretic peptide levels are associated with poor clinical outcomes in pediatric acute lung injuryManagement of acute decompensated heart failure.Current clinical applications of spectral tissue Doppler echocardiography (E/E' ratio) as a noninvasive surrogate for left ventricular diastolic pressures in the diagnosis of heart failure with preserved left ventricular systolic functionB-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.Non-cardiogenic pulmonary edema complicating electroconvulsive therapy: short review of the pathophysiology and diagnostic approach.Out-patient management of chronic heart failure.Effects of Exercise Training versus Attention on Plasma B-type Natriuretic Peptide, 6-Minute Walk Test and Quality of Life in Individuals with Heart Failure.Membrane guanylyl cyclase receptors: an updateEarly Elevated B-Type Natriuretic Peptide Levels are Associated with Cardiac Dysfunction and Poor Clinical Outcome in Pediatric Septic Patients.Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy.Clinical findings, natriuretic peptides, and echocardiography: integrating tools to optimize heart failure management.The utility of B-type natriuretic peptide in the diagnosis of heart failure in the emergency department: a systematic reviewNational Academy of Clinical Biochemistry (NACB) laboratory medicine guidelines on the clinical utilization and analytical issues for cardiac biomarker testing in heart failureNoninvasive assessment of acute dyspnea in the ED.Use of natriuretic peptide assay in dyspnea.Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansionPulmonary vascular complications in asymptomatic children with portal hypertensionElevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women.Natriuretic peptides in heart failure: where we are, where we are going.Natriuretic peptides in therapy for decompensated heart failure.Review on natriuretic peptides: where we are, where we are going.Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.Plasma natriuretic peptides in children and adolescents with obstructive sleep apnea and their changes following intervention.NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy.Comparison of TIVA and Desflurane Added to a Subanaesthetic Dose of Propofol in Patients Undergoing Coronary Artery Bypass Surgery: Evaluation of Haemodynamic and Stress Hormone Changes.Individual variability in cardiac biomarker release after 30 min of high-intensity rowing in elite and amateur athletes.
P2860
Q26825665-F47498F6-15CC-4707-94E4-4E650C2850CCQ27005797-A14DAA28-5809-484B-8FE1-0D84505B8B5BQ30483582-9DDFCB0F-58B1-40E5-82BB-6C65454E7665Q30487626-CFC209C5-47A2-4E7E-9A6C-4459A03B80EFQ30541142-71548F16-364A-4126-AF51-6A75350893BDQ33823313-62918AE2-9B96-495E-BE31-A5A325C96408Q33902623-E341EAA4-2C40-4E6E-9A19-208DA302BC4EQ34477250-9450F371-4221-418A-8CF1-01E34FBDAAA3Q34508301-0B6FCEA5-6982-4F0E-9C0B-602258C33B64Q34566491-E5A8EB0E-6133-4E2C-AD7B-1E1CF53BD4D6Q35355806-BD8B50EA-3AF9-49BE-AFE7-1EC8760F464EQ35567228-66D79219-7599-4D25-B36D-F1D1DB19C306Q35570909-2BF5DA06-AC77-40BA-AB79-4B4E451309F8Q35584978-518B18DE-A918-45EC-B83E-55AF0F2BAF7DQ35593180-8148833C-2E8E-42B9-8215-5C021DD6DCE4Q35659776-ABCD867D-15CB-474B-8BF7-8BDB23560998Q35741318-B86244A2-E94F-4481-B035-FDF3AD99B514Q35968889-92873883-CEC8-4AD7-A5D0-F4920CCE74C1Q36171031-DED784CF-D075-499D-99C0-9737C1DD73ACQ36249926-DC73D645-9FBF-4C63-B4B5-D1BA0B1F80D9Q36509225-A1D34063-3695-418B-BB22-653D52EC4AD9Q36525043-4B91DA87-4891-4F0E-9D4D-89196553EF60Q36721760-8B933084-8ED4-40C3-9312-0596E60E048BQ36836161-C21BA1E0-14FE-4D09-964C-C7EC65A4438FQ36836551-97469A10-C0E2-4389-822F-E039E2609F10Q36861935-DF21B1CD-627B-49ED-ADE1-381F6ACB29A3Q37020155-24502439-4C61-4850-A215-5C58EFAE34A6Q37073838-DD45BA4D-C5D9-4E70-A65D-D5B7C68FB083Q37228387-CA0FC9FA-80D3-4449-A564-4618A729099BQ37356547-8CA44938-1629-4911-A0F8-3B9CBB65E45FQ37438575-096312E0-D76A-45E8-97D2-4C2A5A7CCBFDQ37468738-BE02BBB5-2EB5-4433-98E3-D2C91C5E354AQ37790310-DCCAF531-D5A6-451A-8E3E-768FE2662535Q37928970-71EEE0D2-3883-4DA4-A5EC-13CEDE5BA7FFQ38089931-A6EC151D-1A5F-4CB9-A804-861CFF9CFF13Q38096829-6F6BD8C9-9860-4C54-8AF5-F0B70AD1CED5Q38561217-12336CE7-577E-4282-90D9-508D2D0210CFQ38758203-D5F31BD0-A133-481F-81EC-816C7CF64B33Q39467679-1B452788-0770-4302-858F-6E96524B79F4Q40607059-93A01E6B-326B-4207-A70B-55BACEDD62F0
P2860
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
BNP Consensus Panel 2004: A cl ...... es in cardiovascular diseases.
@ast
BNP Consensus Panel 2004: A cl ...... es in cardiovascular diseases.
@en
type
label
BNP Consensus Panel 2004: A cl ...... es in cardiovascular diseases.
@ast
BNP Consensus Panel 2004: A cl ...... es in cardiovascular diseases.
@en
prefLabel
BNP Consensus Panel 2004: A cl ...... es in cardiovascular diseases.
@ast
BNP Consensus Panel 2004: A cl ...... es in cardiovascular diseases.
@en
P2093
P2860
P1476
BNP Consensus Panel 2004: A cl ...... es in cardiovascular diseases.
@en
P2093
Alan Maisel
BNP Consensus Panel
David A Morrow
Gary S Francis
John C Burnett
Judd Hollander
Mandeep R Mehra
Marc A Silver
Peter A McCullough
W Brian Gibler
P2860
P356
10.1111/J.1527-5299.2004.03271.X
P433
P577
2004-09-01T00:00:00Z